Detalhe da pesquisa
1.
Clinical trial links oncolytic immunoactivation to survival in glioblastoma.
Nature
; 623(7985): 157-166, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37853118
2.
Mechanisms and therapeutic implications of hypermutation in gliomas.
Nature
; 580(7804): 517-523, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32322066
3.
How I treat secondary CNS involvement by aggressive lymphomas.
Blood
; 142(21): 1771-1783, 2023 11 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37702537
4.
How I treat neurologic complications in patients with lymphoid cancer.
Blood
; 139(10): 1469-1478, 2022 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34479368
5.
Clinical efficacy and safety of chimeric antigen receptor T-cell therapy for mantle cell lymphoma with secondary central nervous system involvement.
Br J Haematol
; 203(5): 774-780, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37584155
6.
Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma.
Blood
; 134(11): 860-866, 2019 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31320380
7.
Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study.
Blood
; 133(4): 299-305, 2019 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-30523119
8.
Pemetrexed in Recurrent or Progressive Central Nervous System Lymphoma: A Phase I Multicenter Clinical Trial.
Oncologist
; 25(9): 747-e1273, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32520407
9.
Challenges in the Treatment of Newly Diagnosed and Recurrent Primary Central Nervous System Lymphoma.
J Natl Compr Canc Netw
; 18(11): 1571-1578, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33152700
10.
Early imaging marker of progressing glioblastoma: a window of opportunity.
J Neurooncol
; 148(3): 629-640, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32602020
11.
PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma.
Blood
; 129(23): 3071-3073, 2017 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28356247
12.
Working plan for the use of patient-reported outcome measures in adults with brain tumours: a Response Assessment in Neuro-Oncology (RANO) initiative.
Lancet Oncol
; 19(3): e173-e180, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29508764
13.
High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for patients with primary central nervous system lymphoma in first complete remission.
Cancer
; 123(16): 3073-3079, 2017 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28369839
14.
Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone.
J Neurooncol
; 135(3): 581-591, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28975467
15.
Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomas.
J Neurooncol
; 132(1): 181-188, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28116649
16.
Central nervous system involvement by Waldenström macroglobulinaemia (Bing-Neel syndrome): a multi-institutional retrospective study.
Br J Haematol
; 172(5): 709-15, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26686858
17.
Is it time to revisit R-CHOP for primary CNS lymphoma?
Blood
; 134(3): 221-222, 2019 07 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31320363
18.
Immunotherapy response assessment in neuro-oncology: a report of the RANO working group.
Lancet Oncol
; 16(15): e534-e542, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26545842
19.
Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non-small cell lung cancer.
Cancer
; 121(23): 4165-72, 2015 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26308485
20.
Extent of resection and overall survival for patients with atypical and malignant meningioma.
Cancer
; 121(24): 4376-81, 2015 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26308667